European Commission, Joint Research Centre, Institute for Transuranium Elements, P.O. Box 2340, D-76125, Karlsruhe, Germany.
Dalton Trans. 2010 Feb 7;39(5):1366-74. doi: 10.1039/b918426k. Epub 2009 Dec 2.
Literature reports of the efficacy of para-sulfonatocalix[6]- and calix[8]-arenes as U(vi) complexants indicated that they might be useful for in vivo chelation of the novel therapeutic alpha-emitter (230)U. We have studied the complexation of U(vi) with para-sulfonatocalix[6]arene and para-sulfonatocalix[8]arene by time resolved laser induced fluorescence spectroscopy and using competition methods with Chelex resin and 4-(2-pyridylazo)resorcinol in simplified and in biological media. New thermodynamic parameters describing the stability of U(vi)-para-sulfonatocalix[n]arene [n = 6, 8] complexes were obtained. Although the interactions are strong, the complexes do not exhibit sufficient stability to compete with carbonate ions and serum proteins for complexation of U(vi) under physiological conditions.
文献报道磺化杯[6]芳烃和磺化杯[8]芳烃作为 U(vi)螯合剂的功效,表明它们可能对新型治疗性 α 发射体 (230)U 的体内螯合有用。我们通过时间分辨激光诱导荧光光谱法以及在简化和生物介质中使用 Chelex 树脂和 4-(2-吡啶偶氮)间苯二酚进行竞争方法研究了 U(vi)与对磺化杯[6]芳烃和对磺化杯[8]芳烃的络合。获得了描述 U(vi)-对磺化杯[n]芳烃[n = 6,8]配合物稳定性的新热力学参数。尽管相互作用很强,但这些配合物在生理条件下与碳酸根离子和血清蛋白竞争 U(vi)的络合时,其稳定性不足以竞争。